Fubon Financial Holdings
VC Fund
Taipei, Taiwan
Fubon Financial Holdings is a VC fund in Taipei focused on Biotechnology and Software. Fubon Financial Holdings has built a strong lineup of financial service companies. Its major subsidiaries include Fubon Life, Taipei Fubon Bank, Fubon Bank (Hong Kong), Fubon Bank (China), Fubon Insurance, Fubon Securities, and Fubon Asset Management. Fubon Financial Holdings had total assets of US$283.9 billion as of the end of 2019, rankingsecond among Taiwan’s financial holding companies, and it has been the most profitable company in the industry in terms of earnings per share (EPS) for eleven consecutive years. The company was also named to the Fortune Global 500 for the second consecutive year in 2019.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 8%
Last updated:
For AI agents: llms.txt
Industries Fubon Financial Holdings invests in
Stages Fubon Financial Holdings invests in
Countries Fubon Financial Holdings invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $5M–$152M
- Venture - Series Unknown
- $21M–$700M
Investment Focus
Industry
- Biotechnology 4 (33%)
- Software 3 (25%)
- Medical 2 (17%)
- Agriculture 2 (17%)
- Health Care 2 (17%)
Stage
- Series A 6 (50%)
- Venture - Series Unknown 3 (25%)
- Series B 1 (8%)
- Series D 1 (8%)
- Corporate Round 1 (8%)
Country
- Taiwan 5 (42%)
- United States 3 (25%)
- Israel 1 (8%)
- Indonesia 1 (8%)
- United Kingdom 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Victor Kung
President & Chief Financial Officer
|
President & Chief Financial Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Humanoid is an artificial intelligence and robotics company that develops humanoid robots for industrial and commercial applications. Its technology includes modular wheeled and bipedal robotic platforms, as well as KinetIQ, an AI framework for robot fleet orchestration and autonomous operation across different environments. The company designs itsrobots to perform repetitive and physically demanding tasks in industries such as manufacturing, logistics, warehousing, and retail. It also collaborates with technology, cloud computing, and research partners to support the development and deployment of its robotic systems. Humanoid focuses on integrating artificial intelligence with robotics to create general-purpose automation solutions that can operate in real-world industrial settings. | $152M / Series A / Jul 21, 2026 | ||
| Wonder is a food technology company that operates a mealtime platform offering restaurant meals, prepared foods, meal kits, and food delivery through a unified ordering experience. It develops and manages food preparation, ordering, and delivery using proprietary technology, including its Infinite Kitchen food robotics platform. The companypartners with chefs and restaurant brands to provide a variety of meal options that customers can order through its platform. It also manages the preparation and fulfillment process to support delivery and pickup services across its locations. Additionally, Wonder expands its food ecosystem through the operation and integration of restaurant concepts, meal kit services, and delivery capabilities. | $700M / Venture - Series Unknown / Mar 19, 2024 | ||
| AnnJi Pharmaceutical is a clinical-stage drug development company that specializes in developing small molecules that address unmet medical needs in the areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy’s disease, and SBMA (Spinal and bulbar muscular atrophy). Thefocus of the company is on creating global collaborations and business partnerships in the late-stage product development and commercialization of pharmaceutical drugs. | $21.1M / Venture - Series Unknown / Jul 05, 2023 | ||
| EdenFarm is an agriculture supply chain startup that delivers fresh agricultural products such as fruit, vegetables, and dry goods to restaurants in Indonesia. EdenFarm works directly with local farmers and central markets all across the country. Eden Farm strives to create a food market with stable prices and aims to improve the quality of life oflocal producers by focusing on the B2B Industry with a technology-supported food ecosystem. | $13.4M / Series A / Jan 30, 2023 | ||
| EdenFarm is an agriculture supply chain startup that delivers fresh agricultural products such as fruit, vegetables, and dry goods to restaurants in Indonesia. EdenFarm works directly with local farmers and central markets all across the country. Eden Farm strives to create a food market with stable prices and aims to improve the quality of life oflocal producers by focusing on the B2B Industry with a technology-supported food ecosystem. | $13.5M / Series B / Jan 30, 2023 | ||
| Triller is an AI-powered music video app and talent discovery platform that allows users to create professional-looking videos in a matter of seconds. Pick a song, select the portion of the song you want to use, snap a few takes and with the tap of a button you have a celebrity-quality music video starring you and your friends. Triller reliessolely on organic growth and has more than 23 million downloads, with celebrities from Kevin Hart to Vanessa Hudgens regularly using the app to create their own music videos. Triller raised a $4.5M seed round in May 2016 and a $5M Series A funding round in February 2018, with plans to expand its AI technology and develop the brand as a talent discovery platform. | $200M / Venture - Series Unknown / Aug 29, 2022 | ||
| Immunwork develops innovative drugs that combine targeting and effector functions to enhance efficacy and safety. The company focuses on creating ultralong-acting analogues, such as TE-8214, an octreotide derivative, and TE-8035, a modified human insulin. Immunwork's drug pipeline addresses immune system diseases and leverages a proprietarytechnology platform. The company is involved in clinical trials to validate its therapeutic solutions. | $23.7M / Series A / Mar 08, 2022 | ||
| OmniEyes is an IT company that collects and digitizes live street videos and converts them using AI technologies. | $5M / Series A / Jan 26, 2022 | ||
| Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders. | Series A / Aug 23, 2021 | ||
| Nanotech Energy is a supplier of graphene, graphene oxide, and graphene supper batteries. The company has exclusively licensed from UCLA leading super battery and supercapacitor intellectual property that has been applied to the development of energy storage and delivery devices that can store and deliver energy at significantly higher rates thantoday's batteries and can significantly affect the world of energy storage and delivery.Nanotech also offers graphene products that have the potential to revolutionize lives with applications in batteries, transparent conducting electrodes, conductive inks, printed electronics, conductive epoxy, antistatic coatings, and EMI (electromagnetic interference) shielding, enabling clients to charge devices in just a fraction of the time with an energy storage system that runs three times longer than traditional batteries. | $64M / Series D / Aug 10, 2021 | ||
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Fubon Financial Holdings invest in?
Fubon Financial Holdings invests primarily in Biotechnology, Software and Medical startups, most often at Series A and Venture - Series Unknown stage. Most of the 12 investments tracked by Shizune back companies in Taiwan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Fubon Financial Holdings's check size?
Fubon Financial Holdings typically joins rounds of $5M–$152M at Series A and $21M–$700M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Fubon Financial Holdings participates in.
How do I contact Fubon Financial Holdings?
Public channels for Fubon Financial Holdings include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Fubon Financial Holdings?
The team at Fubon Financial Holdings includes Victor Kung (President & Chief Financial Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
